Partner notification of chlamydia infection in primary care: randomised controlled trial and analysis of resource use
- 15 December 2005
- Vol. 332 (7532) , 14-19
- https://doi.org/10.1136/bmj.38678.405370.7c
Abstract
Objective To evaluate the effectiveness of a practice nurse led strategy to improve the notification and treatment of partners of people with chlamydia infection. Design Randomised controlled trial. Setting 27 general practices in the Bristol and Birmingham areas. Participants 140 men and women with chlamydia (index cases) diagnosed by screening of a home collected urine sample or vulval swab specimen. Interventions Partner notification at the general practice immediately after diagnosis by trained practice nurses, with telephone follow up by a health adviser; or referral to a specialist health adviser at a genitourinary medicine clinic. Main outcome measures Primary outcome was the proportion of index cases with at least one treated sexual partner. Specified secondary outcomes included the number of sexual contacts elicited during a sexual history, positive test result for chlamydia six weeks after treatment, and the cost of each strategy in 2003 sterling prices. Results 65.3% (47/72) of participants receiving practice nurse led partner notification had at least one partner treated compared with 52.9% (39/68) of those referred to a genitourinary medicine clinic (risk difference 12.4%, 95% confidence interval −1.8% to 26.5%). Of 68 participants referred to the clinic, 21 (31%) did not attend. The costs per index case were £32.55 for the practice nurse led strategy and £32.62 for the specialist referral strategy. Conclusion Practice based partner notification by trained nurses with telephone follow up by health advisers is at least as effective as referral to a specialist health adviser at a genitourinary medicine clinic, and costs the same. Trial registration Clinical trials: NCT00112255.Keywords
This publication has 15 references indexed in Scilit:
- Knowledge of sex partner treatment for past bacterial STI and risk of current STISexually Transmitted Infections, 2005
- Coverage and uptake of systematic postal screening for genital Chlamydia trachomatis and prevalence of infection in the United Kingdom general population: cross sectional studyBMJ, 2005
- Screening for chlamydiaThe Lancet, 2005
- Effect of Expedited Treatment of Sex Partners on Recurrent or Persistent Gonorrhea or Chlamydial InfectionNew England Journal of Medicine, 2005
- Chlamydia—a testing issueThe Lancet, 2005
- Effectiveness and cost-effectiveness of a pharmacy-based screening programme for Chlamydia trachomatis in a high-risk health centre population in Amsterdam using mailed home-collected urine samplesInternational Journal of STD & AIDS, 2004
- The chlamydia screening studies: rationale and designSexually Transmitted Infections, 2004
- Modelling the healthcare costs of an opportunistic chlamydia screening programmeSexually Transmitted Infections, 2004
- A Survey of Contact Tracing Practice for Sexually Transmitted Diseases in GUM Clinics in England and WalesInternational Journal of STD & AIDS, 1999
- Genital Chlamydia trachomatis infections in primary careBMJ, 1996